Chief Medical Officer
HonorHealth Research Institute
Dr. Gordon is a medical oncologist with a special interest in sarcoma and phase I investigational drug development. His career has focused on translational cancer therapy trials, and he has had the opportunity to lead efforts in cutaneous oncology both at Indiana University as well as at the HonorHealth Research Institute where they are now focusing a major effort on the Arizona Rare Cancer Initiative. The organization is investing significant effort in the strategy for developing treatments for uveal melanoma and rare sarcomas including translational studies as well as pre-clinical models.
He is the former President and CEO of Pinnacle Oncology Hematology in Scottsdale, AZ, and is now Chief Medical Officer at the HonorHealth Research Institute in Scottsdale, AZ, Clinical Professor of Medicine at the University of Arizona College of Medicine in Phoenix and the Clinical Professor at the Translational Genomics Research Institute in Phoenix. Dr Gordon was instrumental in the clinical development of antiangiogenic agents for the treatment of cancer and more recently, led the effort for the development of new I/O therapies to treat cancer.